Clinical Trial Update: Blinatumomab in Refractory Active Childhood Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and preliminary efficacy of blinatumomab in children with refractory active systemic lupus erythematosus. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Blinatumomab (blinatumomab)

Snippet

Sponsor: Mao Jianhua | Conditions: Systemic Lupus Erythematosus (SLE), Children | Phase 1 | Status: RECRUITING